Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salmeterol-induced vertigo

A López-Guillen1, L Marquès, M T López-Llorente

  • 1Centro de Rehabilitación Respiratoria, Sabadell, Spain.

The European Respiratory Journal
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ELECLA trial: final results of perioperative chemotherapy with fluoropyrimidine and oxaliplatin in mismatch repair proficient locally advanced colon cancer.

ESMO open·2026
Same author

Compartment-specific immune response in Mytilus galloprovincialis to Vibrio splendidus revealed by haemolymph proteomics.

Fish & shellfish immunology·2025
Same author

The Sting Challenge Test Shows High Negative Predictive Value in Patients Receiving Venom Immunotherapy.

Journal of investigational allergology & clinical immunology·2025
Same author

Comparative transcriptomics reveals different grades of susceptibility to a bacterial infection in bivalves.

Fish & shellfish immunology·2025
Same author

Parental perceptions of early interceptive orthodontic intervention in children and adolescents: a cross-sectional study.

European journal of paediatric dentistry·2025
Same author

Highly efficient Zn<sub>1-</sub> Cd <sub></sub> S catalysts with sphalerite structures synthesized <i>via</i> a novel green method for hydrogen production by water splitting.

RSC advances·2024
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Vertigo, a type of dizziness, was reported in a patient using salmeterol, a long-acting bronchodilator. This adverse drug reaction occurred without cardiovascular changes, suggesting a potential link not previously documented.

Area of Science:

  • Pharmacology
  • Neurology
  • Respiratory Medicine

Background:

  • Salbutamol, a short-acting beta-agonist, is known to cause dizziness and hypotension due to cardiovascular effects.
  • Limited information exists regarding the adverse effects of salmeterol, particularly non-cardiovascular ones like vertigo.

Observation:

  • A case study involving a woman experiencing recurrent episodes of vertigo.
  • Each vertigo episode lasted approximately 36 hours and followed salmeterol inhalation.

Findings:

  • The patient reported four separate instances of vertigo, each temporally linked to salmeterol use.
  • No cardiovascular alterations were noted during these episodes, differentiating it from salbutamol's known side effects.

Implications:

Related Experiment Videos

  • This case suggests a potential association between salmeterol and vertigo as an adverse drug reaction.
  • Further investigation is warranted to understand the mechanism and prevalence of salmeterol-induced vertigo.
  • Clinicians should consider vertigo as a possible side effect of salmeterol, especially in the absence of cardiovascular issues.